Alzheimer's disease

Leqembi gains approval for Alzheimer’s treatment in Israel
Pharmaceutical Business Review
Fri, 07/12/24 - 11:12 am
Eisai
Israel
Alzheimer's disease
Leqembi
BioArctic
FDA approval is just the beginning. Now Lilly’s Kisunla faces the tough Alzheimer’s market
Pharma Voice
Tue, 07/9/24 - 11:24 am
Eli Lilly
Kisunla
Alzheimer's disease
Eli Lilly Alzheimer's drug approved by US FDA
Reuters
Tue, 07/2/24 - 03:09 pm
Eli Lilly
donanemab
Alzheimer's disease
FDA
Kisunla
Two Senior Cassava Employees Subjects in Federal Probes After Former Advisor Indicted for Fraud
BioSpace
Tue, 07/2/24 - 11:37 am
Cassava Sciences
Alzheimer's disease
legal
fraud
Eisai and Biogen launch Alzheimer's drug Leqembi in China
Reuters
Fri, 06/28/24 - 11:18 am
Eisai
Biogen
Alzheimer's disease
Leqembi
China
Where the future of Alzheimer's drugs is heading
Axios
Fri, 06/28/24 - 11:15 am
Alzheimer's disease
drug development
Eli Lilly
5 FDA Decisions to Watch in the Second Half of 2024
BioSpace
Mon, 06/24/24 - 11:29 am
FDA
Eli Lilly
donanemab
Alzheimer's disease
Adaptimmune
afami-cel
advanced synovial sarcoma
Lykos Therapeutics
MDMA
PTSD
Bristol Myers Squibb
KarXT
schizophrenia
Daiichi Sankyo
AstraZeneca
Dato-DXd
non-small cell lung cancer
What Would a Donanemab Approval Mean for Leqembi?
BioSpace
Mon, 06/24/24 - 10:47 am
Eli Lilly
donanemab
Biogen
Eisai
Leqembi
FDA
Alzheimer's disease
How Roche is finding better ways to diagnose brain conditions like Alzheimer’s and Parkinson’s disease
Pharma Voice
Tue, 06/18/24 - 11:34 am
Roche
biomarkers
Alzheimer's disease
Parkinson's Disease
R&D
Eli Lilly Scores Another Major Win and Lines Up Its Next Blockbuster
Motley Fool
Sun, 06/16/24 - 08:54 pm
Eli Lilly
Alzheimer's disease
donanemab
Lilly’s adcomm win shows amyloid and tau will likely dominate Alzheimer’s — for now
Pharma Voice
Thu, 06/13/24 - 10:50 am
Eli Lilly
Alzheimer's disease
donanemab
amyloid
tau
Alzheimer’s Drug Developer Alzheon Closes $100M Series E Financing
Genetic Engineering News
Wed, 06/12/24 - 11:29 pm
Alzheon
clinical trials
funding
Alzheimer's disease
valiltramiprosate
Lilly Alzheimer’s drug gets unanimous backing of FDA panel
BioPharma Dive
Mon, 06/10/24 - 06:09 pm
Eli Lilly
FDA
donanemab
Alzheimer's disease
FDA accepts Eisai's subcutaneous Leqembi filing, sets January 25 decision date
Fierce Pharma
Mon, 06/10/24 - 11:19 am
Eisai
Biogen
Leqembi
FDA
Alzheimer's disease
FDA staff raise no major concerns about Eli Lilly Alzheimer's drug
Reuters
Thu, 06/6/24 - 09:11 pm
Eli Lilly
FDA
Alzheimer's disease
donanemab
FDA lays out donanemab concerns ahead of meeting, as Lilly vigorously defends safety
Fierce Biotech
Thu, 06/6/24 - 11:45 am
Eli Lilly
donanemab
FDA
Alzheimer's disease
Lucy Therapeutics secures $12.5m for neurological treatment development
Pharmaceutical Business Review
Wed, 05/29/24 - 11:49 am
Lucy Therapeutics
funding
Alzheimer's disease
Parkinson's Disease
Otsuka Drops Alzheimer’s Agitation Drug Following Phase III Failure
BioSpace
Wed, 05/22/24 - 11:20 am
Otsuka
Alzheimer's disease
Alzheimer's agitation
clinical trials
AVP-786
Voyager doses first patient with anti-tau antibody in Alzheimer’s trial
Clinical Trials Arena
Mon, 05/20/24 - 11:05 am
Voyager Therapeutics
Alzheimer's disease
clinical trials
VY-TAU01
Eisai starts rolling submission for injectable version of Alzheimer's drug with US FDA
Reuters
Tue, 05/14/24 - 11:03 pm
Eisai
Biogen
Leqembi
FDA
Alzheimer's disease

Pages